PTCT FY2025 SEC EDGAR DEF 14A #150 of 168 in industry

Ptc Therapeutics, Inc. CEO pay ratio

The CEO earned $23.3M in FY2025 against median worker pay of $245,742 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
DE
Filing date
2026-04-20
Industry
Chemicals & Pharmaceuticals
Industry rank
#150/168

Data updated August 2026

Subscribe to Ptc Therapeutics, Inc. CEO pay filing updates (RSS)

CEO-to-worker pay ratio
7:1
Below Average (Scale: 0–1000:1)
CEO pay
$23.3M
Median worker
$245,742

Answer first

Ptc Therapeutics, Inc.'s FY2025 CEO total of $23.3M ranks #126 of 1,423 complete filings; its 7:1 pay ratio ranks #1314. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $245,742. Industry placement uses the FY2025 SIC-28 peer cohort (# 150 of 168, 11th percentile - among the lower quartile of industry peers by pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#126
$23.3M of 1,423 FY2025
Ratio rank
#1314
7:1 of 1,423
Industry pct
11th
among the lower quartile of industry peers by pay ratio

How Ptc Therapeutics, Inc. ranks nationally

Ptc Therapeutics, Inc. CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$23,266,326 Top 9% higher than 91% of 1,423 companies

$0–$2,500,000: 304 companies (21%). Below this entry. $2,500,000–$5,000,000: 182 companies (13%). Below this entry. $5,000,000–$7,500,000: 208 companies (15%). Below this entry. $7,500,000–$10,000,000: 192 companies (13%). Below this entry. $10,000,000–$12,500,000: 139 companies (10%). Below this entry. $12,500,000–$15,000,000: 91 companies (6%). Below this entry. $15,000,000–$17,500,000: 88 companies (6%). Below this entry. $17,500,000–$20,000,000: 54 companies (4%). Below this entry. $20,000,000–$22,500,000: 24 companies (2%). Below this entry. $22,500,000–$25,000,000: 34 companies (2%). This entry sits in this band. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Ptc Therapeutics, Inc. vs. Chemicals & Pharmaceuticals peers

CEO total pay ($23.3M) against pay ratio (7:1) for Ptc Therapeutics, Inc. (marked) and its 4 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both06105785.612211571.218317356.724423142.34.2:114.1:124.0:133.9:143.8:1CEO total payPay ratio (CEO : median worker)Ptc Therapeutics, Inc., CEO total pay: 23266326 · Pay ratio (CEO : median worker): 7:1Ptc Therapeutics, Inc.Collegium Pharmaceutical, Inc, CEO total pay: 1715846 · Pay ratio (CEO : median worker): 8:1Collegium Pharmaceutical, IncOmeros Corp, CEO total pay: 1533248 · Pay ratio (CEO : median worker): 8:1Omeros CorpAlzamend Neuro, Inc., CEO total pay: 130000 · Pay ratio (CEO : median worker): 6:1Alzamend Neuro, Inc.Edgewise Therapeutics, Inc., CEO total pay: 443614 · Pay ratio (CEO : median worker): 6:1Edgewise Therapeutics, Inc.
Ptc Therapeutics, Inc. vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Ptc Therapeutics, Inc.'s structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Ptc Therapeutics, Inc.

Complete DEF 14A pay-ratio filings for this CIK across FY2021–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
7:1
FY2025
vs prior FY
0:1
from FY2024 7:1
CEO $ YoY
+214%
$23.3M latest
Filings shown
5
FY2021–2025
Ptc Therapeutics, Inc. CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2021 $11.0M - $243,357 3:1 -
2022 $7.2M -35% $224,401 9:1 +6:1
2023 $8.9M +25% $215,581 5:1 -4:1
2024 $7.4M -17% $220,097 7:1 +2:1
2025 $23.3M +214% $245,742 7:1 0:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 1070081, FY2021–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
7:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$23.3M
Companies in Industry
168
vs. Industry Median
Below
#150 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

Ptc Therapeutics, Inc.: near-parity Item 402(u) ratio

Ptc Therapeutics, Inc.'s FY2025 ratio 7:1 ranks #150 of 168 Chemicals & Pharmaceuticals filers (11th percentile). the CEO earned 7× the median employee ($245,742) in FY2025.

At $245,742 median worker pay, the FLOOR stamp is near pay-parity territory under PEAK CEO total.

CEO Total Pay

$23.3M

FY2025 Summary Compensation, well above median

Pay Ratio

7:1

Below typical

Ptc Therapeutics, Inc. in the lower Chemicals & Pharmaceuticals third

Ptc Therapeutics, Inc.'s FY2025 ratio 7:1 ranks #150 of 168 Chemicals & Pharmaceuticals filers (11th percentile). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Ptc Therapeutics, Inc.'s $23.3M CEO total is above the $7.9M industry median CEO pay.

Dollar rank #126 and ratio rank #1314 split - treat 7:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$23.3M
Median Employee Pay
$245,742
Pay Ratio
7:1
Filing Date
2026-04-20

Company Info

Ticker
PTCT
CIK
1070081
Industry
Chemicals & Pharmaceuticals
SIC Code
2834
State
DE
View SEC filings →
SEC EDGAR DEF 14A for CIK 1070081, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. Ptc Therapeutics, Inc.'s FY2025 ratio 7:1 ranks #150 of 168 Chemicals & Pharmaceuticals filers (11th percentile).

Read with Ptc Therapeutics, Inc.

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps FLOOR · PEAK · ELITE-MED.

Ralph Lauren Corp · PEAK

ABS(ceo_total_comp) peer at $23.3M (Δ $806 lighter vs Ptc Therapeutics, Inc.); EXTREME · LOW-MED vs this page's FLOOR · PEAK · ELITE-MED.
Equifax Inc · PEAK

ABS(ceo_total_comp) peer at $23.4M (Δ $121K heavier vs Ptc Therapeutics, Inc.); STEEP · HIGH-MED vs this page's FLOOR · PEAK · ELITE-MED.
Hp Inc · PEAK

ABS(ceo_total_comp) peer at $23.1M (Δ $163K lighter vs Ptc Therapeutics, Inc.); STEEP · HIGH-MED vs this page's FLOOR · PEAK · ELITE-MED.
Hewlett Packard Enterprise Co · PEAK

ABS(ceo_total_comp) peer at $23.5M (Δ $216K heavier vs Ptc Therapeutics, Inc.); HIGH · HIGH-MED vs this page's FLOOR · PEAK · ELITE-MED.
Church & Dwight Co Inc /de/ (SIC 28 pole)

Church & Dwight Co Inc /de/ stamps FLOOR · UNFILED nearest in-SIC by ABS(pay_ratio) to Ptc Therapeutics, Inc.'s FLOOR filing.
National dual ranks · #126/#1314

Ptc Therapeutics, Inc.'s FY2025 package sits #126 by CEO dollars and #1314 by ratio under PEAK · FLOOR.
Ratio primer · FLOOR

Ptc Therapeutics, Inc.'s FLOOR stamp sits in the lower Item 402(u) band - start with how the ratio is disclosed before comparing peers.
Data sourced from SEC EDGAR DEF 14A for Ptc Therapeutics, Inc. (CIK 1070081), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.